Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib significantly improved hair loss and lesions in a patient with overlapping autoimmune disorders.

Baricitinib and its combination with lonafarnib improve fat cell formation in certain genetic disorders.

Methotrexate and azathioprine are equally effective and well-tolerated for treating lichen planopilaris.

α-MSH may help treat skin inflammation and fibrosis.

FM dyes effectively stain Merkel cells for long-term observation.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

Fibroblast Growth Factor-9 (FGF-9) can help improve heart function in diabetic mice after a heart attack by reducing inflammation and harmful changes to the heart's structure.

The dual-wavelength laser system effectively reduces EFFC symptoms with minimal side effects.

Terbinafine can cause skin reactions when exposed to sunlight, so sun exposure should be avoided during treatment.

Fesoterodine is effective and safe for elderly patients with overactive bladder.

Targeting specific metabolic and ionic pathways may improve alopecia areata treatment.

The 1298CC genotype in RA patients leads to higher methotrexate toxicity, while the 1298AA genotype results in better treatment response.

Combining FCS and MPG is more effective for treating stable vitiligo than using either alone.

Both treatments improved alopecia areata, but methotrexate caused more skin darkening, while triamcinolone caused skin lightening and thinning.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Tofacitinib is effective and safe for treating alopecia areata with a good drug survival rate.

Frontal fibrosing alopecia is increasing, especially in postmenopausal women, and treatment with finasteride can improve it.

FCO2 laser is a better treatment for alopecia areata than intralesional steroids.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

Lotion with fucoidan from brown seaweed improved skin and reduced allergy symptoms in mice with dermatitis.

Mycophenolic acid effectively improved hair and nail growth in a lupus patient.

Mini pulse corticosteroid therapy with oral dexamethasone is effective and has fewer side effects for treating extensive alopecia areata.

Methotrexate caused a rare skin rash in a rheumatoid arthritis patient, which resolved after stopping the drug.

A 30-year-old man with rare skin conditions improved with antibiotics and surgery, hinting at a link to rosacea.

Combining minoxidil and fibroblast growth factor is more effective for treating male hair loss than using either alone.

Methotrexate may effectively and safely treat hair loss in children, with notable improvement after 12-15 months.

The folate-cyclodextrin conjugate targets cancer cells more precisely, potentially reducing chemotherapy side effects.

Oral dutasteride is a recommended first treatment for frontal fibrosing alopecia.